PetMed Express Inc. (NASDAQ:PETS) insider Bruce S. Rosenbloom sold 1,500 shares of the business’s stock in a transaction on Monday, October 10th. The shares were sold at an average price of $21.00, for a total transaction of $31,500.00. Following the transaction, the insider now owns 41,767 shares in the company, valued at approximately $877,107. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

PetMed Express Inc. (NASDAQ:PETS) opened at 20.38 on Thursday. The firm’s 50-day moving average is $20.41 and its 200 day moving average is $19.29. PetMed Express Inc. has a 12-month low of $15.61 and a 12-month high of $21.16. The firm has a market cap of $411.27 million, a P/E ratio of 19.41 and a beta of 1.07.

PetMed Express (NASDAQ:PETS) last issued its quarterly earnings results on Monday, July 25th. The company reported $0.32 EPS for the quarter, beating analysts’ consensus estimates of $0.31 by $0.01. PetMed Express had a net margin of 9.09% and a return on equity of 25.97%. The business had revenue of $72.50 million for the quarter. During the same quarter in the previous year, the business earned $0.29 earnings per share. The firm’s revenue was up 1.3% on a year-over-year basis. Equities analysts forecast that PetMed Express Inc. will post $1.11 earnings per share for the current year.

Insider Buying and Selling by Quarter for PetMed Express (NASDAQ:PETS)

Hedge funds and other institutional investors have recently modified their holdings of the company. NEXT Financial Group Inc boosted its position in shares of PetMed Express by 167.2% in the second quarter. NEXT Financial Group Inc now owns 5,354 shares of the company’s stock valued at $100,000 after buying an additional 3,350 shares in the last quarter. BNP Paribas Arbitrage SA boosted its position in shares of PetMed Express by 101.2% in the second quarter. BNP Paribas Arbitrage SA now owns 6,206 shares of the company’s stock valued at $116,000 after buying an additional 3,121 shares in the last quarter. Royal Bank of Canada boosted its position in shares of PetMed Express by 19.6% in the second quarter. Royal Bank of Canada now owns 6,423 shares of the company’s stock valued at $120,000 after buying an additional 1,053 shares in the last quarter. Cutler Group LP boosted its position in shares of PetMed Express by 832.0% in the second quarter. Cutler Group LP now owns 7,064 shares of the company’s stock valued at $132,000 after buying an additional 8,029 shares in the last quarter. Finally, Bank of Montreal Can purchased a new position in shares of PetMed Express during the second quarter valued at about $143,000. Hedge funds and other institutional investors own 75.97% of the company’s stock.

A number of research analysts recently issued reports on PETS shares. Zacks Investment Research upgraded shares of PetMed Express from a “hold” rating to a “buy” rating and set a $23.00 target price on the stock in a research report on Wednesday, July 27th. Credit Suisse Group AG reiterated a “sell” rating and set a $13.00 target price on shares of PetMed Express in a research report on Tuesday, August 16th.

PetMed Express Company Profile

PetMed Express, Inc (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.

5 Day Chart for NASDAQ:PETS

Receive News & Stock Ratings for PetMed Express Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express Inc. and related stocks with our FREE daily email newsletter.